The National Hospital of Sri Lanka is a government hospital in Colombo, Sri Lanka. Founded in 1864 as the General Hospital, it is the leading hospital in Sri Lanka and is controlled by the central government. The hospital has 18 intensive care units and 21 operating theaters and 3,404 beds.

There are 3,404 (2020) beds in National Hospital of Sri Lanka.

During the past decade, National Hospital of Sri Lanka conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital of Sri Lanka" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Medical Health Research Infrastructure Council, Australia" with 1 trials as a collaborator, "National Health and Medical Research Council, Australia" with 1 trials as a collaborator, "National Heart Foundation, Australia" with 1 trials as a collaborator and "The University of New South Wales" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital of Sri Lanka" are "Crohn's Disease" (2 trials), "Coronary Artery Disease" (1 trials), "Diabetes Mellitus Type 1 or 2" (1 trials), "Hypertension" (1 trials) and "Intracerebral Haemorrhage (ICH)" (1 trials). Many other conditions were trialed in "National Hospital of Sri Lanka" in a lesser frequency.

Most popular intervention types in "National Hospital of Sri Lanka" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Filgotinib" (2 trials), "Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug) or placebo" (1 trials), "Placebo to match filgotinib" (1 trials) and "telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital of Sri Lanka" are 5 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital of Sri Lanka". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in National Hospital of Sri Lanka, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital of Sri Lanka, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".